NCT06679920 Study With a Newly Optical Coherence Tomography Probe for Optimizing Bladder Cancer Diagnosis and Treatment
| NCT ID | NCT06679920 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Amsterdam UMC |
| Condition | Bladder Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 15 participants |
| Start Date | 2024-12 |
| Primary Completion | 2025-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 15 participants in total. It began in 2024-12 with a primary completion date of 2025-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to see if a new designed optical coherence tomography catheter can be used in bladder cancer in patients undergoing a transurethral resection of a bladder tumour. The main question it aims to answer is: \- Is the optical coherence tomography catheter feasible in capturing images of bladder tumours and normal bladder wall during a transurethral resection of a bladder tumour? Participants will undergo measurements with a new optical coherence tomography device during the transurethral resection of their bladder tumour(s).
Eligibility Criteria
Inclusion Criteria: * Age \> 18 years. * Have at least 1 suspected bladder tumour seen at cystoscopy. * Have a bladder that is accessible for cystoscopy. * Be in a physical condition to undergo a TURBT. * Eligible patients must be fully informed about the study and written signed informed consent must be obtained prior to any study related investigation/intervention. Exclusion Criteria: * Pregnant or lactating women. * The only tumour site is at the bladder neck. * The tumour(s) is larger than 2 centimetres in diameter. * \>5 tumours present. * Solely a suspected flat lesion present.
Frequently Asked Questions
Who can join the NCT06679920 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Bladder Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06679920 currently recruiting?
Yes, NCT06679920 is actively recruiting participants. Visit ClinicalTrials.gov or contact Amsterdam UMC to inquire about joining.
Where is the NCT06679920 trial being conducted?
This trial is being conducted at Amsterdam, Netherlands, Amsterdam, Netherlands.
Who is sponsoring the NCT06679920 clinical trial?
NCT06679920 is sponsored by Amsterdam UMC. The trial plans to enroll 15 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.